Yes, Herceptin is a drug used in certain form of Breast cancer which overexpresses the HER-2 protein, enabling angiogenesis and rapid tumour growth. Herceptin is the trade name for monoclonal antibodies against the HER-2 receptor which block these, limiting their function and improving patient prognosis.
There are other examples to, monoclonal antibodies against IgE antibody to prevent type 1 hypersentivity e.g. peanut allergy.
A single clone, ie a bunch of identical antibodies. As opposed to polyclonal antibodies, which are different clones even though they bind the same antigen.
Monoclonal antibodies were developed by César Milstein and Georges Köhler in 1975, for which they were awarded the Nobel Prize in Physiology or Medicine in 1984. They used hybridoma technology to produce identical antibodies that target a single antigen, revolutionizing biomedical research and therapy.
Yes, monoclonal antibodies can be specific for multiple antigenic determinants if those determinants share similar structural features that allow the antibody to bind to them. This property is known as cross-reactivity. However, some monoclonal antibodies are designed to target a single specific antigenic determinant to ensure high specificity in diagnostic or therapeutic applications.
Monoclonal antibodies can be used to protect against disease, help diagnose a wide variety of illnesses and detect the presence of drugs or viral and bacterial products. It is these specific traits that make it so valuable.
monoclonal antibodies lies on the principal of producing antibodies and monocloaal means the specificity and avidity for antigen i.i they recognize a single epitope. firstly the mouse is innoculated with appropriate antigen and spleen cells are isolated from it. then the myeloma cells grown in vitro and spleen cells which are isolated are fused in the polyethyleneglycol (PEG) and cultured in HAT medium. the following result comes; 1. spleen cells die in vitro 2. spleen-myeloma hybrid cells survive 3. unfused myeloma cells die in HAT medium surviving hybrid cells are clonned and used further.
Monoclonal antibodies (mAb or moAb) are monospecific antibodies that are made by identical immune cells that are all clones of a unique parent cell, in contrast to polyclonal antibodies which are made from several different immune cells. Monoclonal antibodies have monovalent affinity, in that they bind to the same epitope. Given almost any substance, it is possible to produce monoclonal antibodies that specifically bind to that substance; they can then serve to detect or purify that substance. This has become an important tool in biochemistry, molecular biology and medicine. When used as medications, the non-proprietary drug name ends in -mab (see "Nomenclature of monoclonal antibodies"), and many immunotherapy specialists use the word mab anacronymically.
how do monoclonal antibodies help controlling plant disease?
Monoclonal-- Genetically engineered antibodies specific for one antigen.
monoclonal antibodies
Monoclonal antibodies are highly specific, targeting a single antigen, while polyclonal antibodies can target multiple antigens. Monoclonal antibodies are produced from a single clone of cells, resulting in uniformity, while polyclonal antibodies are produced from multiple clones of cells, leading to variability.
Monoclonal antibodies are commonly used to fight a large number of diseases including cancer. The monoclonal antibodies fight the disease by targeting a certain antigen and recruiting the body's natural immune system to destroy the antigen-infected cells.
Immunotherapy
yes
Monoclonal Antibodies
To kill things
Fully human monoclonal antibodies are derived entirely from human sources, making them less likely to cause immune reactions. They are generally more effective and have a lower risk of side effects compared to humanized monoclonal antibodies, which contain some non-human components. Fully human monoclonal antibodies are often preferred for medical treatments due to their higher specificity and reduced risk of adverse reactions.
Monoclonal antibodies are made by fusing a specific type of immune cell called a B cell with a cancer cell to create a hybrid cell called a hybridoma. The hybridoma cell then produces identical antibodies that can target a specific antigen. These antibodies are then harvested and purified for use in various medical treatments and research.